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Abstract
Vascular smooth muscle cells (VSMCs) play important roles in the physiology and patho-
physiology of the blood vessels. In a healthy adult organism, VSMCs are quiescent, but 
after a blood vessel injury, they undergo phenotypic modulation from the contractile 
phenotype to the synthetic phenotype, characterized by high activity in migration, prolif-
eration and proteosynthesis. This behavior of VSMCs can lead to stenosis or obliteration 
of the vascular lumen. For this reason, VSMCs have tended to be avoided in the construc-
tion of blood vessel replacements. However, VSMCs are a physiological and the most 
numerous component of blood vessels, so their presence in novel advanced vascular 
replacements is indispensable. Either differentiated VSMCs or stem cells as precursors 
of VSMCs can be used in the reconstruction of the tunica media in these replacements. 
VSMCs can be obtained from blood vessels (usually from subcutaneous veins) taken 
surgically from the patients and can be expanded in vitro. During in vitro cultivation, 
VSMCs lose their differentiation markers, at least partly. These cells should therefore 
be re-differentiated by seeding them on appropriate scaffolds by composing cell culture 
media and by mechanical stimulation in dynamic bioreactors. Similar approaches can 
also be applied for differentiating stem cells, particularly adipose tissue-derived stem 
cells, toward VSMCs for the purposes of vascular tissue engineering.
Keywords: vascular replacements, adipose tissue-derived stem cells, transforming 
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1. Introduction
VSMCs are the most numerous cell types in blood vessels, where they are located in the 
medial layer of the vascular wall, that is, in the tunica media. These cells are necessary for 
the physiological functioning of blood vessels, particularly for vasoconstriction, for vasodi-
latation and for synthesis of vascular extracellular matrix. These cells are also implicated in 
pathological changes in blood vessels during atherosclerosis, hypertension, diabetic angiopa-
thy and other vascular disorders. After biochemical or mechanical damage to blood vessels, 
VSMCs undergo phenotypic modulation, that is, they make the transition from their original 
quiescent contractile phenotype to a synthetic phenotype, characterized by increased proteo-
synthesis and by activation of the migration and growth of VSMCs [1–4]. These changes often 
lead to irreversible damage to blood vessels, including stenosis and occlusion. Ischemia of the 
tissues supplied by the damaged vessels is then manifested by serious disorders, for example, 
heart failure, brain stroke or necrosis of leg tissues, which can result in amputation of the leg.
Low patency of arteries can be treated by balloon angioplasty or by endarterectomy. However, 
in cases of severe blood vessel damage, vascular replacements need to be implanted, usually 
in the form of bypasses spanning the damaged region of the original vessel.
Vascular bypass grafts can be obtained from four sources: autologous, allogenous, xenogenous 
or artificial. Autologous grafts, that is, grafts derived from the patient, have the drawbacks of 
limited availability, donor site morbidity, burden to the patient due to additional surgery 
and, in the case of implantation of a vein into an arterial position, also mechanical mismatch. 
Allogeneous transplants, that is, transplants derived from the same species, or xenogenous 
transplants, that is, transplants derived from a different species, are associated with a risk 
of immune rejection, disease transmission and, when they are fixed in glutaraldehyde, also 
potential release of cytotoxic molecules [5, 6]). In view of these problems, artificially con-
structed vascular grafts have been considered as very promising for future applications.
Artificial grafts currently used in clinical practice are made of synthetic polymers, namely 
polyethylene terephthalate (PET), expanded polytetrafluoroethylene (ePTFE) and, in some 
cases, also polyurethane [5, 7, 8]. The first generation of these prostheses was constructed as 
cell-free, that is, without the reconstruction of any layer of the natural blood vessel. However, 
the inner surface of the prosthesis attracted cell types participating in thrombus formation, 
immune reaction and prosthesis restenosis, that is, thrombocytes, inflammatory cells (leu-
cocytes, lymphocytes, monocytes, macrophages), and also VSMCs. VSMCs migrated on the 
prosthesis mainly from the sites of the anastomosis of the graft with the original vessel and 
were prone to excessive proliferation. In addition, precursors of VSMCs, originating from the 
bone marrow and circulating in the blood, can adhere to the inner surface of the prosthesis 
and can proliferate [9]. All these events can lead to considerable stenosis, obliteration and 
failure of vascular prostheses, especially medium-diameter vascular grafts (up to 8 mm in 
diameter) and small-diameter vascular grafts (up to 4 mm in diameter). Attempts have there-
fore been made to cover the luminal surface of the prosthesis with a confluent, phenotypically 
mature and semi-permeable endothelial cell layer, which is considered optimal for prevent-
ing thrombosis, inflammatory cell adhesion and VSMC hyperplasia [5, 7, 8].
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However, in advanced vascular replacements, it is necessary to reconstruct not only the endothelial 
cell layer, that is, the main component of the tunica intima, but also the other layers of the vascular 
wall, particularly the tunica media with VSMCs as the physiological component of natural blood 
vessels. It is necessary only to control the proliferation activity of these cells precisely and to direct 
them toward a differentiated quiescent contractile phenotype. In modern tissue engineering, it is 
also desirable to differentiate stem cells toward VSMCs, particularly stem cells derived from adi-
pose tissue, which is relatively easily accessible and is available in sufficient quantities [10, 11].
This chapter summarizes our own experience and the experience of other authors in 
re-differentiating VSMCs on vascular constructs via appropriate cultivation substrates, the com-
position of cell culture media, cell–cell interaction and mechanical stimulation in dynamic bioreac-
tors. Similar approaches have also been applied for differentiating stem cells, particularly adipose 
tissue-derived stem cells, toward VSMCs for the purposes of vascular tissue engineering.
2. Use of differentiated VSMCs in blood vessel tissue engineering
As mentioned earlier, attempts have been made to reconstruct the tunica intima on artificial 
vascular replacements, and these replacements have been used sporadically in clinical prac-
tice [7, 8]. At the same time, the tunica media has been reconstructed only rarely in vascular 
replacements, due to the tendency of VSMCs to proliferate excessively, and these attempts 
still remain at the experimental level. However, as was mentioned earlier, the presence of the 
tunica media enhances the functionality of artificially constructed blood vessels, if the VSMCs 
gain their quiescent contractile phenotype [12]. This phenotype is usually lost during the 
expansion of VSMCs after they have been harvested from blood vessels obtained surgically 
from patients. The contractile phenotype can be restored by an appropriate structure and 
composition of the scaffolds, by appropriate composition of cell culture media, by appropri-
ate cell–cell interactions and by appropriate mechanical stimulation of VSMCs in dynamic 
cell culture systems, especially if the factors mentioned here are applied in combination.
2.1. Structure and composition of the scaffolds
As concerns the structure of the scaffolds, three-dimensional (3D) porous scaffolds are more 
physiological than two-dimensional (2D) scaffolds, because 3D scaffolds better mimic the archi-
tecture of the native tunica media and enable a multilayered arrangement of VSMCs [13, 14]. The 
differentiation response of VSMCs to the uniaxial stress generated by a dynamic cell culture 
system was more pronounced in 3D scaffolds than on 2D scaffolds [15].
As concerns the chemical composition of the scaffolds, attempts are being made to fabricate 
these scaffolds from degradable materials, such as synthetic polymers (e.g., polylactides, 
polyglycolides, polycaprolactone and their copolymers), natural polymers (collagen, elastin, 
fibronectin, laminin, fibrin) and combinations of these materials [14–20]. Degradable scaffolds 
are used for vascular tissue engineering, because the scaffolds will gradually be removed and 
replaced by a newly regenerated vascular tissue. In addition, some natural polymers maintain 
the VSMCs in a differentiated contractile phenotype, for example, elastin and proteins of the 
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cell basement membrane, namely type IV collagen and laminin, while other natural polymers, 
such as fibronectin and vitronectin, stimulate the phenotypic modulation of VSMCs toward 
the synthetic phenotype and VSMC migration and proliferation [18, 21, 22]. The role of type I 
collagen is ambiguous. Polymeric fibrillary type I collagen in a healthy blood vessel keeps the 
VSMCs in their quiescent state, but degraded or denatured type I collagen supports VSMC 
proliferation [21, 23]. Scaffolds obtained by decellularization of various tissues, including 
blood vessels, recently emerged as very promising structures for cardiovascular tissue engi-
neering. After decellularization, the tissues lose most of their immunogenicity and could even 
be used for xenogeneic transplantation. At the same time, these scaffolds retain their original 
biochemical composition and mechanical properties [11, 12, 19, 20, 24].
2.2. Composition of the cell culture medium
Another important issue in the reconstruction of the tunica media is the composition of the 
cell culture medium. In the initial phase of colonization of the scaffolds with VSMCs, the 
migration and proliferation of these cells and their synthesis of ECM molecules is desirable, 
and therefore a standard serum-supplemented medium can be used. At the same time, the 
scaffolds should be seeded with a high number of VSMCs in order to shorten their migratory 
and proliferative phase as much as possible. It is known that the confluence of VSMCs and 
the development of cell–cell contact support the re-differentiation of VSMCs toward the con-
tractile phenotype [25]. When the scaffolds are well populated with VSMCs, it is necessary to 
achieve the quiescent differentiated contractile phenotype of VSMCs. For this purpose, chem-
ically defined serum-free or serum-low media are used, for example, media supplemented 
with transforming growth factor-β (TGF-β) [26–28] or with heparin [29]. At the same time, 
heparin supports endothelialization of the prosthesis [30], which also contributes to the devel-
opment of the contractile phenotype in VSMCs, for example, by producing sulfated heparin-
like glycosaminoglycans [2, 18, 31], nitric oxide [32, 33] and by developing contacts between 
VSMC and endothelial cells, that is, myoendothelial gap junctions [27].
2.3. Interactions of VSMCs with endothelial cells and with other VSMCs
VSMCs co-cultured in direct contact with endothelial cells showed more pronounced differ-
entiation toward the contractile phenotype (manifested by increased expression of contractile 
proteins, that is, SM1 and SM2 isoforms of smooth muscle myosin heavy chain, calponin 1 and 
smooth muscle α-actin) than VSMCs co-cultured with endothelial cells without direct contact 
with these cells. This effect was mediated by connexin 43 (Cx43), an important component 
of myoendothelial gap junctions. Inhibition of gap junctional communication pharmacologi-
cally or by knock down of Cx43 in endothelial cells blocked TGF-β signaling and VSMC dif-
ferentiation [27]. However, the gap junctions between VSMCs are a more controversial issue. 
On the one hand, an increased number of these junctions and upregulation of Cx43 have been 
shown to be associated with undesirable VSMC proliferation and vascular diseases. On the 
other hand, when increased expression of Cx43 in VSMCs was induced by TGF-β1, these cells 
enhanced the expression of smooth muscle α-actin (SM α-actin), calponin and SM1 myosin 
heavy chain, that is, markers of VSMC differentiation toward the contractile phenotype [34].
In comparison with other connexins, for example, Cx37, Cx43 is highly mechanosensitive. The 
exposure of human coronary artery smooth muscle cell to shear stress of 5 dyn/cm2, but not 
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to physiological shear stress of 12 dyn/cm2, caused the dysfunction of Cx40/Cx43 heterotypic 
myoendothelial gap junctions, which may be replaced by homotypic Cx43/Cx43 channels and 
induced the transition of VSMCs to the synthetic phenotype, which was manifested by decreased 
expression of smooth muscle myosin heavy chain (SM-MHC) and calponin and by increased 
release of platelet-derived growth factor-BB (PDGF-BB). At the same time, the VSMCs under 
shear stress of 5 dyn/cm2 were randomly oriented, while under shear stress of 12 dyn/cm2, these 
cells were aligned in the flow direction [35].
In our experiments, we investigated the effects of periodical uniaxial stretching of VSMCs on 
the Cx43 expression. Mechanical stimulation of VSMCs was performed using STREX equip-
ment (B Bridge International, Ltd). VSMCs were seeded in flexible silicone chambers coated 
with type I collagen and fibronectin. After a 2-day static culture, the VSMCs were subjected 
to stretch at a frequency of 0.5 Hz and an amplitude of 5%. After a further period of 48 h, the 
frequency was changed to 1 Hz. The changes in Cx43 expression were tested by qRT-PCR. At 
near-physiological conditions (frequency of 1 Hz and amplitude of 5%), the expression imme-
diately rose almost 5 fold, with the maximum in the first 30 min. At a lower degree of stimula-
tion (at a frequency of 0.5 Hz and an amplitude of 5%), the maximal expression was delayed 
to about 60 min, and it was considerably lower. For longer time periods, the expression of 
Cx43 decreased again (Figure 1). VSMCs were also stained by immunofluorescence to show 
the changes in the arrangement and the distribution of the contractile protein SM α-actin. 
After stretching, the SM α-actin was more intensely stained than in the control static culture 
and was organized into filaments, especially in cells after 24 h of stretching (Figure 2).
2.4. Mechanical loading of VSMCs in a dynamic culture system
In general, dynamic cultivation of VSMCs is an important tool for restoring the contractile dif-
ferentiated phenotype of these cells [16, 19]. It has been shown repeatedly that differentiation 
of VSMCs requires pulsatile stress and cyclic strain, that is, components of the hemodynamic 
stress to which blood vessels are exposed in vivo [36].
As concerns pulsatile stress, rabbit aortic VSMCs were seeded onto rubber-like elastic, three-
dimensional poly(lactide-co-caprolactone) scaffolds and were exposed to a pulsatile flow of 
Figure 1. Relative mRNA expression of connexin 43 (GJA1) in rat aortic smooth muscle cells after uniaxial stretching in 
the STREX dynamic cell culture system (B bridge international, ltd.) for 0–48 h at a frequency of 0.5 Hz (dark) or 1 Hz 
(light).
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the culture medium (flow rate 130 ml/min, pressure 25 mmHg with a pulse of 1 Hz, amplitude 
of radial distention 5%, exposure 8 weeks). The pulsatile strain and the shear stress enhanced 
the VSMC proliferation and collagen production. However, at the same time, the expression 
of SM α-actin, an early marker of VSMC differentiation, was upregulated 2.5-fold in com-
parison with the value in VSMCs under static conditions, and the VSMCs were aligned in a 
direction radial to the distending direction, that is, similarly as in native blood vessels in vivo, 
whereas the VSMCs were randomly oriented under static conditions [37].
The behavior of VSMCs in a pulsatile bioreactor can be further modulated by the presence or 
absence of endothelial cells. Endothelial cells were seeded on the opposite side of a porous 
polycarbonate membrane and were placed in contact with a collagen gel containing VSMCs. 
The presence of the endothelial cells increased the VSMC size and the expression of the con-
tractile proteins, namely SM α-actin and SM-MHC. Absence of endothelial cells decreased 
the expression of SM α-actin and SM-MHC without affecting the size of the VSMCs. The 
proliferation of VSMCs was not affected by the presence or absence of endothelial cells [38].
As concerns cyclic strain, collagen-based gels laden with primary human umbilical artery 
VSMCs were exposed to a 10% cyclic strain at 0.5 Hz for 5 days. Cyclic stimulation promoted 
cell-driven collagen matrix bi-axial compaction, enhancing the mechanical strength of the 
strained samples with respect to the static controls. Moreover, cyclic strain had a positive 
effect on VSMC behavior: the cells maintained their contractile phenotype and spread uni-
formly throughout the thickness of the walls of collagen-based tubular structures [39].
The effect of cyclic strain can be further modulated by the presence of various growth factors. 
For example, VSMCs in a 3D collagen type 1 matrix were exposed to a 10% circumferential 
strain at a frequency of 1 Hz. These conditions increased the gel compaction and the VSMC 
proliferation, which was further enhanced by adding PDGF into the cell culture medium. 
Conversely, the addition of TGF-β strongly inhibited cell proliferation and increased the 
expression of SM α-actin [40]. In a study by Yao et al. [41], rat aortic VSMCs in 70% confluence 
and after starving in a Dulbecco’s Modified Eagle Medium (DMEM) without serum for 24 h 
were subjected to cyclic strain of 10% elongation at 1.25 Hz for 24 h in the Flexercell Tension 
Figure 2. Immunofluorescence of SM α-actin in rat aortic smooth muscle cells in 2-day-old cultures after exposure to 
uniaxial stretching at a frequency of 1 Hz for 4 h (A), 24 h (B) and in control cells without stretching (C). Leica SPE 
confocal microscope (DM 2500 CSQ V-VIS), obj. 63×. Scale bar = 25 μm.
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Plus system. The strain stimulated the secretion of TGF-β1 by VSMCs and upregulated the 
expression of contractile phenotype markers in these cells, namely smooth muscle protein 
22-α (SM22-α), SM α-actin and calponin.
The parameters of the cyclic strain also strongly modulate the VSMC response. For example, 
rat aortic VSMCs were exposed to cyclic strains in vitro with defined parameters, that is, 5% 
strain, considered as physiological, and 15% strain, considered as pathological. Both types of 
strain had a frequency of 1.25 Hz and were applied for 24 h. The results showed that 15% strain 
significantly increased VSMC migration and proliferation in comparison with 5% strain [42].
3. Use of stem cells as a source of VSMCs for blood vessel tissue 
engineering
Stem cells have emerged as a promising resource for advanced tissue engineering, including 
vascular tissue engineering. Differentiated VSMCs are often obtained from aged and poly-
morbid patients. These cells show lower proliferation potential than is desirable, as the har-
vested cells need to be expanded in cell culture conditions. In addition, the VSMCs also show 
a higher tendency toward senescence. Another consideration is that these VSMCs are mostly 
of venous origin because it is easier and less invasive to isolate subcutaneous veins than arter-
ies. However, venous VSMCs have different properties from those of arterial VSMCs, for 
example, they are adapted for lower pressure and slower blood circulation in the vein system.
Stem cells are a component of the blood vessels themselves, where they are distributed 
throughout the entire vascular wall, that is, in the subendothelial space of the tunica intima, in 
the tunica media and also in the tunica adventitia. Their primary function is postnatal vasculo-
genesis and regeneration of the vascular wall after injury, but they can also be a cell source for 
vascular tissue engineering [43–45]. However, harvesting stem cells and isolating differenti-
ated VSMCs are associated with similar problems [46].
Other sources of stem cells with the potential to be differentiated into VSMCs are human 
pluripotent stem cells, obtained from embryonic tissues [47, 48] and induced pluripotent stem 
cells (iPSCs) [49–51]. However, the use of these cells, although promising, is associated with 
ethical and legal issues in human embryonic stem cells and with a risk of potential tumorige-
nicity of iPSCs. These complications can be overcome by the use of stem cells isolated from 
extrafetal tissues, for example, placenta [52] and umbilical cord [53] or by the use of stem 
cells from adult tissues, such as bone marrow [36, 54, 55], epidermis, namely hair follicles 
[56] or skeletal muscle [57]. In addition, adult stem cells can be applied in autologous form. 
However, harvesting the adult tissues mentioned here is often invasive and painful, and the 
tissues are obtained in relatively small quantities. Consequently, adipose tissue-derived stem 
cells (ASCs) seem to be the most promising source because the adipose tissue, located sub-
cutaneously, can be obtained by a less invasive method, that is, liposuction, and in relatively 
large quantities.
ASCs have been used relatively widely for experimental vascular tissue engineering. 
The main tools for differentiating ASCs toward VSMCs include composing cell culture 
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media and exerting mechanical stress in dynamic cell culture systems, similarly as for 
the re-differentiation of VSMCs. Examples of results obtained by various authors [10, 11, 
58–67] are summarized in Table 1.
Author Scaffolds Medium supplement Cultivation 
system
Obtained VSMC 
markers
Rodríguez 
et al. [10]
Uncoated tissue culture 
polystyrene dishes 
or dishes coated with 
laminin or collagen
Medium MCDB 131 
with 1% FBS plus 
100 units/ml of heparin
Static SM α-actin, calponin, 
caldesmon, SM22-α, 
SM-MHC, smoothelin
Kim et al. [58] Tissue culture 
polystyrene
Angiotensin II Static SM α-actin, calponin, 
h-caldesmon, SM-MHC
Kim et al. [59] Tissue culture 
polystyrene
Bradykinin Static SM α-actin
Kim et al. [60] Tissue culture 
polystyrene
Thromboxane A
2
 
mimetic U46619
Static SM α-actin, calponin, 
SM-MHC, smoothelin
Nincheri et al. 
[61]
Tissue culture 
polystyrene, microscope 
slides coated with 
gelatine
Sphingosine 
1-phosphate
Static SM α-actin, transgelin, 
cytoskeletal F-actin 
assembly, Ca2+ currents
Wang et al.. 
[62]
Tissue culture 
polystyrene dishes
TGF-β1, BMP-4 Static SM α-actin, SM22-α, 
calponin, SM-MHC
Aji et al. [63] Tissue culture 
polystyrene
TGF-β1, BMP-4 Static SM α-actin, SM22α, 
calponin, SM-MHC
Elçin et al. [64] 8-chamber slides (Labtek) TGF-β1, BMP-4, 
angiotensin II
Static SM α-actin, calponin, 
h-caldesmon SM-MHC
Lachaud et al. 
[65]
Tissue culture 
polystyrene dishes
EGF Static SM α-actin, calponin, 
caldesmon, SM22α, 
desmin, SM-MHC, 
smoothelin-B
Wang et al. 
[66]
Polyglycolic acid mesh TGF-β1, BMP-4 Pulsatile stress SM α-actin, calponin, 
SM-MHC
Harris et al. 
[11]
Decellularized saphenous 
vein
angiotensin II, SPC, 
TGF-β1
Bioreactor 
generating:
Tension
Compression
Pressure
Perfusion
calponin, caldesmon, 
SM-MHC
Rashidi et al. 
[67]
Plasma-treated silicon 
membranes with collagen 
I
TGF-β1 Cyclic strain SM α-actin, SM22-α, 
h-caldesmon, calponin3
TGF-β1: transforming growth factor-β1; BMP-4: bone morphogenetic protein-4 (a polypeptide belonging to the TGF-β 
superfamily); SM α-actin: α-isoform of smooth muscle actin; SM22-α: smooth muscle protein 22-α; SM-MHC: smooth 
muscle myosin heavy chain; Transgelin: actin cross-linking/gelling protein in fibroblasts and smooth muscle cells; SPC: 
sphingosylphosphorylcholine; EGF: epidermal growth factor.
Table 1. Culture conditions for differentiation of ASCs into VSMCs and the obtained markers of differentiation.
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For our experiments, the ASCs were isolated from lipoaspirates obtained from patients by 
liposuction under their informed consent and ethical approval. Lipoaspirates of subcutane-
ous adipose tissue were taken from three different regions, that is, the abdominal region and 
the inner or outer side of the thighs. Liposuction was performed under low negative pres-
sure (−200 mmHg) and under high negative pressure (−700 mmHg). The ASCs were then 
harvested by a method originally described by Estes et al. [68], with a slight modification 
described in our earlier study [69].
3.1. Differentiation of ASCs toward VSMCs by the composition of the cell culture 
medium
In our first set of experiments, we attempted to optimize the composition of the cell cul-
ture media in a conventional static cell culture system in order to differentiate the ASCs 
toward VSMCs. First, three types of culture media were tested, namely a DMEM medium 
(Sigma-Aldrich, Cat. No. D5648) with 10% of fetal bovine serum (FBS), SmGM®-2 Smooth 
Muscle Growth Medium-2 BulletKit® (SMGM, Lonza, USA, Cat. No. CC-3182) and 
Endothelial Growth Medium-2 (EGM-2, Lonza, USA, Cat. No. 3162). These media alone, 
that is, without additional supplementation, did not promote the differentiation of ASCs 
into VSMCs. Therefore, we supplemented the media with transforming growth factor-β1 
(TGF-β1; 2.5 ng/mL, Abcam) and with bone morphogenetic protein-4 (BMP-4; 2.5 ng/ml, 
Sigma-Aldrich) because this combination of growth factors showed greater differentiation 
efficiency than TGF-β1 or BMP-4 alone or in combination with angiotensin II [64]. The 
addition of TGF-β1 into SMGM-2 and EGM-2 media caused rapid proliferation and subse-
quent detachment of the ASCs. The differentiation experiments were therefore performed 
with DMEM +2% of FBS + TGF-β1 + BMP-4. The addition of TGF-β1 increased the prolif-
eration of ASCs in comparison with DMEM +2% FBS without any supplement. When the 
ASCs were cultured with TGF-β1 and BMP-4 for three days, immunofluorescence staining 
revealed the formation of SM α-actin-containing filaments and an increasing number of 
calponin-positive cells (Figure 3A-C). In later culture intervals (days 14–17), cells with 
slight positivity for desmin and sporadic SM-MHC-positive cells were also detected. Cells 
cultured without the supplements only sporadically contained SM α-actin filaments or 
calponin (Figure 3D and E). In our experiments, we observed individual differences in 
proliferation and differentiation among the ASCs from various patients and also among 
the cells taken from the same patient but from different regions of the body.
3.2. Differentiation of ASCs toward VSMCs by the composition of the cell culture 
medium and by mechanical load
In our second set of experiments, we studied the differentiation of ASCs toward VSMCs by com-
bining cell differentiation media with mechanical load. The blood pumped by the heart generates 
several mechanical stimuli on the arterial wall, such as the wall shear stress affecting endothelial 
cells, and also the pressure force and the cyclic strain stress. These types of stimuli promote or 
accelerate the differentiation and the phenotypic maturation of ASCs and other stem cells into 
VSMCs [36, 55, 66]. In order to simulate the effects of these mechanical stimuli, we have devel-
oped a unique dynamic cultivation system. This system consists of special cultivation chambers 
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Figure 4. Cultivation chambers used for mechanical stimulation (left). The use of transparent surfaces allows microscopic 
live-cell imaging (right).
and a pressure generation system. The design of the chamber allows the use of rigid substrates 
(glass) or flexible substrates (cast silicone). A rigid substrate is used for evaluating the effect of 
the pressure force. A flexible substrate simulates an elastic arterial wall. The pressure force that 
is applied mimics the dilatation and constriction of the arterial wall by generating cyclic strain 
stress. To improve their hydrophilicity, the substrates are plasma treated. In addition, these sub-
strates can be coated with collagen or fibrin gels to improve the adhesion and the initial pro-
liferation of the cells. After cell seeding, the chamber is hermetically sealed to allow controlled 
stimulation (Figure 4). The pressure generation is maintained by a computer-controlled custom-
built linear syringe pump. A pressure-based feedback-controlling algorithm is implemented to 
Figure 3. Immmunofluorescence staining of SM α-actin (red) and calponin (green) in ASCs on day 3 of differentiation 
(A–C) in a medium containing TGF-β and BMP-4. Immunofluorescence staining of desmin (D) on day 14 and of 
SM-MHC (E) on day 17. Cell nuclei are visualized with Hoechst #33258 (blue). Olympus IX 71 microscope, objective ×20 
and ×40, scale 100 μm and 50 μm, respectively.
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maintain stable conditions. Pressure pulses are generated between two set points that simulate 
systolic and diastolic pressure. Maximum pressure can be set up to 300 mmHg (40 kPa), with a 
maximum pulse rate of up to 180 beats per minute (3 Hz).
Our experimental results, obtained in the dynamic culture system described above, indicated 
positive effects of pressure stimulation on the differentiation of ASCs toward VSMCs. ASCs in 
low passages 2–4, with initial density of approx. 70,000 cells/cm2, were cultured in high glu-
cose DMEM medium (Sigma-Aldrich, Cat. No. D5648), supplemented with 2% FBS, TGF-β1 
(2.5 ng/mL, Abcam) and BMP-4 (2.5 ng/ml, Sigma-Aldrich) for 3 or 7 days under static culture 
conditions or under dynamic pulse pressure stimulation. This stimulation was set to physi-
ological 120/80 mmHg (15.9/10.6 kPa) and pulse rate simulating 60 beats per minute (1 Hz). 
The cell culture medium was replaced after 3 days. The ASCs were stained for SM α-actin 
(Sigma-Aldrich, Cat. No. S2547), an early marker of VSMC differentiation, and for calponin 
(Abcam, Cat. No. ab46794), an intermediate marker of VSMC differentiation, and the cell nuclei 
were counterstained with Hoechst #33258. Pressure loading supported ASC proliferation after 
3 days (Figure 5B) and after 7 days (Figure 5D). This was manifested by a higher cell population 
Figure 5. Immunofluorescence staining of SM α-actin (red) and calponin (green) in ASCs cultured embedded in a fibrin 
gel on glass under static conditions (A, C) and under dynamic conditions (B, D), using the system depicted in Figure 4. 
A, B: 3 days of cultivation; C, D: 7 days of cultivation. Cell nuclei are counterstained with Hoechst #33258. IX71 Olympus 
microscope, DP71 digital camera, obj. × 10.
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Figure 6. Capillary formation in the co-culture model of ASCs with endothelial cells. A: Vascular network formed by 
endothelial cells in the co-culture model, endothelial cells stained against VE-cadherin. B: Detail of vascular sprouting; 
VE-cadherin in green, CD146 (a marker of pericytes) in red. C: Stabilization of capillaries by perivascular cells after 
7 days of co-culture; VE-cadherin in green, SM α-actin in red. D: Detail of the close contact between perivascular cells and 
endothelial cells; VE-cadherin in green, SM α-actin in red. Nikon Ti-E inverted fluorescence microscope with a CARV 
II confocal scanner.
density than in the static culture (Figure 5A and C). The ASCs were positively stained for SM 
α-actin on all samples. Moreover, increased numbers of cells positively stained for calponin 
were found in ASCs cultured in fibrin gel under pulse pressure on day 7 (Figure 5D). This sug-
gests that the differentiation of ASCs into VSMCs in the presence of TGF-β1 and BMP-4 was 
significantly enhanced by dynamic pressure loading.
3.3. Differentiation of ASCs in co-culture with vascular endothelial cells
In our third set of experiments, we studied the behavior of ASCs in co-culture with vascu-
lar endothelial cells. ASCs are known to possess the ability to stimulate endothelial cells to 
form capillaries. In a co-culture model of ASCs and endothelial cells, the ASCs in close con-
tact with endothelial cells differentiated after 7 days into pericyte-like cells, which stained 
positively for SM α-actin and stabilized the wall of newly formed capillaries (Figure 6). 
Similar results were achieved in a study by Rohringer et al. [70], who co-cultured ASCs 
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and vascular endothelial cells in a fibrin gel and demonstrated that the proximity of ASCs 
and endothelial cells stimulated the formation of tubular structures by endothelial cells, 
which were stabilized by ASCs developing the characteristics of pericytes. Recent studies 
have documented similarities between mesenchymal stem cells and pericytes. Pericytes 
are contractile cells that are in close contact with endothelial cells in capillaries and serve 
to control the blood flow. When grown in vitro, pericytes express similar surface antigens 
as ASCs (CD73, CD90 or CD105) [71] and lack hematopoietic markers (CD45) and endo-
thelial markers (CD31, von Willebrand factor, VE-cadherin). Pericytes are also capable 
of multipotential differentiation, for example, adipogenic, osteogenic, chondrogenic and 
myogenic differentiation [72]. However, the level of CD146, which is considered to be 
a marker of pericytes, differs greatly among different isolations of ASCs (in our experi-
ence from 0.5–90%). CD146 (also known as MCAM, S-endo-1, MUC18 or P1H12) is not 
expressed solely in pericytes. It is also considered to be a marker of endothelial progeni-
tor cells and endothelial cells. It was recently shown that CD146 acts as a receptor for 
Wnt5a and regulates cell migration [73] or that it is involved in controlling the formation 
of the blood–brain barrier, where it ensures communication between endothelial cells and 
pericytes [74]. In the co-culture model of endothelial cells with ASCs, it remains elusive 
whether every ASC that is in close contact with an endothelial cell can act as a pericyte, or 
whether pericytes form a subpopulation of the heterogeneous population of ASCs with a 
specific, irreplaceable function.
4. Conclusion
Vascular smooth muscle cells (VSMCs) are the most numerous component of the arterial and 
venous wall, and they ensure the physiological functions of blood vessels. Under pathological 
conditions, however, VSMCs lose their differentiation markers, which is accompanied by activa-
tion of migration and proliferation of these cells. This can lead to stenosis or obliteration of the 
injured blood vessels. For this reason, VSMCs were not included in the early generations of vas-
cular replacements, which were either cell-free or pre-endothelialized in vitro. Reconstruction 
of the tunica media containing VSMCs remains at the experimental level. The tunica media can 
be reconstructed with the use of differentiated VSMCs taken from blood vessels (usually sub-
cutaneous veins), isolated surgically or with the use of stem cells, which is a more advanced 
approach. Various types of stem cells have been used for differentiation into VSMCs and for con-
structing vascular replacements, including embryonic stem cells, induced pluripotent stem cells, 
stem cells from extrafetal tissues and stem cells isolated from adult tissues, such as bone marrow, 
skeletal muscle, epidermis and adipose tissue. Adipose-tissue derived stem cells (ASCs) seem to 
be the most promising source of VSMCs because they can be isolated in relatively large quanti-
ties, by relatively non-invasive methods (liposuction) and in autologous form. Differentiation of 
ASCs into VSMCs can be induced by appropriate scaffolds (preferably three-dimensional and 
compliant) by appropriate composition of the cell culture media (e.g., a low-serum medium 
supplemented with TGF-β1 and BMP-4) and particularly by mechanical stimulation in dynamic 
cell culture systems generating pulsatile stress, cyclic strain and pressure stress. In co-cultures 
with endothelial cell forming tubular structures, ASCs form pericyte-like cells.
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